SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520262-18-000005
Filing Date
2018-01-09
Accepted
2018-01-09 16:05:22
Documents
7
Period of Report
2018-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-20180109x8k.htm 8-K 50062
2 EX-99.1 alks-20180109ex9913ba2e3.htm EX-99.1 18962
3 GRAPHIC alks20180109ex9913ba2e3001.gif GRAPHIC 70840
4 GRAPHIC alks20180109ex9913ba2e3002.gif GRAPHIC 98846
5 GRAPHIC alks20180109ex9913ba2e3003.jpg GRAPHIC 84555
6 GRAPHIC alks20180109ex9913ba2e3004.jpg GRAPHIC 75823
7 GRAPHIC alks20180109ex9913ba2e3005.jpg GRAPHIC 79800
  Complete submission text file 0001520262-18-000005.txt   635470
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 18519123
SIC: 2834 Pharmaceutical Preparations